secwatch.observer — SEC 8-K summary
======================================

Issuer:     AXT INC (AXTI)
CIK:        0001051627
Form:       8-K/A
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0001437749-25-023431
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AXT corrects 8-K to show Nasdaq notice date for audit committee non-compliance
------------------------------------------------------------------------------

- Nasdaq notified AXT on July 18, 2025 that audit committee has only two independent directors after Christine Russell's passing.
- Cure period: until earlier of next annual meeting or July 11, 2026; if annual meeting before Jan 7, 2026, evidence due by Jan 7, 2026.
- Board plans to add a new independent director to regain compliance before cure period expires.
- Non-compliance stems from Nasdaq Listing Rule 5605(c)(2)(A) requiring three independent audit committee members.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1051627/000143774925023431/0001437749-25-023431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1051627/000143774925023431/axti20250724_8ka.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-023431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer